Carbon monoxide protects cardiomyogenic cells against ischemic death through L-type Ca2+ channel inhibition

Biochem Biophys Res Commun. 2005 Aug 26;334(2):661-8. doi: 10.1016/j.bbrc.2005.06.142.

Abstract

Carbon monoxide (CO) is known to protect myocardial and vascular cells against injuries due to ischemia-reperfusion or inflammation. We showed that a Ca(2+)-dependent protease calpain promotes necrotic cell death of cardiomyocyte-derived H9c2 cells due to hypoxia through alpha-fodrin proteolysis. Here, we show that ischemia induces necrotic cell death, which is inhibited by either CO, extracellular Ca(2+) deprivation or L-type Ca(2+) channel blockers. A whole cell patch-clamp experiment supports that CO inhibits L-type Ca(2+) channel mediated influx of Ca(2+) and the ischemic death of H9c2 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Calcium / metabolism
  • Calcium Channels, L-Type / drug effects*
  • Carbon Dioxide / administration & dosage*
  • Cell Line
  • Cell Survival / drug effects
  • Membrane Potentials / drug effects
  • Myocardial Ischemia / pathology*
  • Myocardial Ischemia / prevention & control*
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / pathology*
  • Oxidative Stress / drug effects
  • Rats

Substances

  • Calcium Channels, L-Type
  • Carbon Dioxide
  • Calcium